col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Elsevier: Virology
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―28 Prediction of two novel overlapping ORFs in the genome of SARS-CoV-2 Angelo Pavesi
2 [GO] 2021―Jul―23 SARS-CoV-2 and other coronaviruses bind to phosphorylated glycans from the human lung Lauren Byrd-Leotis, Yi Lasanajak, Thomas Bowen, Kelly Baker, Xuezheng Song, Mehul S. Suthar, et al. (+2)
3 [GO] 2021―Jun―28 Insilico study on the effect of SARS-CoV-2 RBD hotspot mutants’ interaction with ACE2 to understand the binding affinity and stability Jyoti Verma, Naidu Subbarao
4 [GO] 2021―Jun―19 Study on SARS-CoV-2 strains in Iran reveals potential contribution of co-infection with and recombination between different strains to the emergence of new strains Peyman Taghizadeh, Sadegh Salehi, Ali Heshmati, Seyed Massoud Houshmand, Kolsoum InanlooRahatloo, Forouzandeh Mahjoubi, et al. (+23)
5 [GO] 2021―Jun―18 Age- and airway disease related gene expression patterns of key SARS-CoV-2 entry factors in human nasal epithelia Mihkel Plaas, Kadri Seppa, Nayana Gaur, Priit Kasenõmm, Mario Plaas
6 [GO] 2021―May―25 Azelastine inhibits viropexis of SARS-CoV-2 spike pseudovirus by binding to SARS-CoV-2 entry receptor ACE2 Shuai Ge, Jiayu Lu, Yajing Hou, Yuexin Lv, Cheng Wang, Huaizhen He
7 [GO] 2021―May―06 Frequency of HLA alleles among COVID-19 infected patients: Preliminary data from Saudi Arabia Fatmah M.A. Naemi, Shurooq Al-adwani, Heba Al-khattabi, Ashwaq Al-nazawi
8 [GO] 2021―Apr―21 Expression of SARS coronavirus 1 spike protein from a herpesviral vector induces innate immune signaling and neutralizing antibody responses Evelyn A. Kurt-Jones, Tim Dudek, Daisuke Watanabe, Leisa Mandell, Jenny Che, Shenghua Zhou, et al. (+8)
9 [GO] 2021―Mar―19 The development and kinetics of functional antibody-dependent cell-mediated cytotoxicity (ADCC) to SARS-CoV-2 spike protein Xuemin Chen, Christina A. Rostad, Larry J. Anderson, He-ying Sun, Stacey A. Lapp, Kathy Stephens, et al. (+4)
10 [GO] 2021―Mar―18 Conflicting and ambiguous names of overlapping ORFs in SARS-CoV-2: A homology-based resolution Irwin Jungreis, Chase W. Nelson, Zachary Ardern, Yaara Finkel, Nevan J. Krogan, Kei Sato, et al. (+6)
11 [GO] 2021―Mar―05 Characterization of neutralizing versus binding antibodies and memory B cells in COVID-19 recovered individuals from India Kaustuv Nayak, Kamalvishnu Gottimukkala, Sanjeev Kumar, Elluri Seetharami Reddy, Venkata Viswanadh Edara, Robert Kauffman, et al. (+14)
12 [GO] 2021―Feb―26 On the road to ending the COVID-19 pandemic: Are we there yet? James Brett Case, Emma S. Winkler, John M. Errico, Michael S. Diamond
13 [GO] 2021―Feb―22 Insights into SARS-CoV-2 evolution, potential antivirals, and vaccines Ahmed S. Abdel-Moneim, Elsayed M. Abdelwhab, Ziad A. Memish
14 [GO] 2021―Feb―22 Updating the influenza virus library at Hokkaido University -It's potential for the use of pandemic vaccine strain candidates and diagnosis Naoki Nomura, Keita Matsuno, Masashi Shingai, Marumi Ohno, Toshiki Sekiya, Ryosuke Omori, et al. (+3)
15 [GO] 2021―Feb―09 Expression, purification and immunological characterization of recombinant nucleocapsid protein fragment from SARS-CoV-2 Teodora Djukic, Maja Mladenovic, Dragana Stanic-Vucinic, Jelena Radosavljevic, Katarina Smiljanic, Ljiljana Sabljic, et al. (+6)
16 [GO] 2021―Feb―04 Exploring the efficacy of naturally occurring biflavone based antioxidants towards the inhibition of the SARS-CoV-2 spike glycoprotein mediated membrane fusion Samiran Mondal, Abhijit Karmakar, Tamanna Mallick, Naznin Ara Begum
17 [GO] 2021―Feb―01 Development of a SARS-CoV-2 nucleocapsid specific monoclonal antibody James S. Terry, Loran BR. Anderson, Michael S. Scherman, Carley E. McAlister, Rushika Perera, Tony Schountz, Brian J. Geiss
18 [GO] 2021―Jan―26 Detecting SARS-CoV-2 3CLpro expression and activity using a polyclonal antiserum and a luciferase-based biosensor Amornrat O'Brien, Da-Yuan Chen, Matthew Hackbart, Brianna J. Close, Timothy E. O'Brien, Mohsan Saeed, Susan C. Baker
19 [GO] 2021―Jan―25 The G614 pandemic SARS-CoV-2 variant is not more pathogenic than the original D614 form in adult Syrian hamsters Charles B. Stauft, Christopher Z. Lien, Prabhuanand Selvaraj, Shufeng Liu, Tony T. Wang
20 [GO] 2021―Jan―13 A novel ratio of CD8+:B-cells as a prognostic marker of coronavirus disease 2019 patient progression and outcome Maria G. Detsika, Kleio Ampelakiotou, Eirini Grigoriou, Katherina Psarra, Edison Jahaj, Charis Roussos, et al. (+4)
21 [GO] 2021―Jan―08 Potential APOBEC-mediated RNA editing of the genomes of SARS-CoV-2 and other coronaviruses and its impact on their longer term evolution Jeremy Ratcliff, Peter Simmonds
22 [GO] 2021―Jan―07 Incomplete humoral response including neutralizing antibodies in asymptomatic to mild COVID-19 patients in Japan Masaru Takeshita, Naoshi Nishina, Saya Moriyama, Yoshimasa Takahashi, Yoshifumi Uwamino, Mika Nagata, et al. (+9)
23 [GO] 2021―Jan―07 Corrigendum to “Analytical and clinical comparison of Viasure (CerTest Biotec) and 2019-nCoV CDC (IDT) RT-qPCR kits for SARS-CoV2 diagnosis” [Virology volume (2021) 154-156] Byron Freire-Paspuel, Patricio Vega-Marino, Alberto Velez, Marilyn Cruz, Franklin Perez, Miguel Angel Garcia-Bereguiain
24 [GO] 2020―Dec―30 Network analysis and molecular mapping for SARS-CoV-2 to reveal drug targets and repurposing of clinically developed drugs Shweta A. More, Akshay S. Patil, Nikhil S. Sakle, Santosh N. Mokale
25 [GO] 2020―Dec―29 Neutralizing antibody-dependent and -independent immune responses against SARS-CoV-2 in cynomolgus macaques Hirohito Ishigaki, Misako Nakayama, Yoshinori Kitagawa, Cong Thanh Nguyen, Kaori Hayashi, Masanori Shiohara, et al. (+2)
26 [GO] 2020―Dec―25 Programmed -1 Ribosomal Frameshifting in coronaviruses: A therapeutic target Jamie A. Kelly, Michael T. Woodside, Jonathan D. Dinman
27 [GO] 2020―Dec―24 Coronavirus infection induces progressive restructuring of the endoplasmic reticulum involving the formation and degradation of double membrane vesicles Elaine M. Mihelc, Susan C. Baker, Jason K. Lanman
28 [GO] 2020―Dec―24 Repurposing of renin inhibitors as SARS-COV-2 main protease inhibitors: A computational study Rana H. Refaey, Mohamed K. El-Ashrey, Yassin M. Nissan
29 [GO] 2020―Dec―16 Dexamethasone inhibits SARS-CoV-2 spike pseudotyped virus viropexis by binding to ACE2 Yongjing Zhang, Jue Wang, Shiling Hu, Zhuoyin Xue, Cheng Wang, Nan Wang
30 [GO] 2020―Nov―28 Effect of SARS-CoV-2 coinfection was not apparent on the dynamics of chronic hepatitis B infection Rentao Yu, Shun Tan, Yunjie Dan, Yanqiu Lu, Juan Zhang, Zhaoxia Tan, et al. (+7)
31 [GO] 2020―Nov―18 Analytical and clinical comparison of Viasure (CerTest Biotec) and 2019-nCoV CDC (IDT) RT-qPCR kits for SARS-CoV2 diagnosis. Byron Freire-Paspuel, Patricio Vega-Mariño, Alberto Velez, Marilyn Cruz, Franklin Perez, Miguel Angel Garcia-Bereguiain
32 [GO] 2020―Oct―31 Immunization with a recombinant fusion of porcine reproductive and respiratory syndrome virus modified GP5 and ferritin elicits enhanced protective immunity in pigs Hui Ma, Xiangmin Li, Jianglong Li, Zekai Zhao, Huawei Zhang, Genxi Hao, et al. (+2)
33 [GO] 2020―Oct―28 A natural food preservative peptide nisin can interact with the SARS-CoV-2 spike protein receptor human ACE2 Rajarshi Bhattacharya, Aayatti Mallick Gupta, Suranjita Mitra, Sukhendu Mandal, Swadesh R. Biswas
34 [GO] 2020―Sep―28 Molecular and serological characterization of SARS-CoV-2 infection among COVID-19 patients Linghua Li, Yuanhao Liang, Fengyu Hu, Huanchang Yan, Yueping Li, Zhiwei Xie, et al. (+7)
35 [GO] 2020―Sep―24 The novel coronavirus Disease-2019 (COVID-19): Mechanism of action, detection and recent therapeutic strategies Elahe Seyed Hosseini, Narjes Riahi Kashani, Hossein Nikzad, Javid Azadbakht, Hassan Hassani Bafrani, Hamed Haddad Kashani
36 [GO] 2020―Aug―26 Quantitative phylogenomic evidence reveals a spatially structured SARS-CoV-2 diversity Leandro R. Jones, Julieta M. Manrique
37 [GO] 2020―Aug―23 Quantifying the effect of remdesivir in rhesus macaques infected with SARS-CoV-2 Hana M. Dobrovolny
38 [GO] 2020―Aug―20 Replicase 1a gene plays a critical role in pathogenesis of avian coronavirus infectious bronchitis virus Jing Zhao, Keran Zhang, Jinlong Cheng, Wenfeng Jia, Ye Zhao, Guozhong Zhang
39 [GO] 2020―Jul―29 A reverse-transcription recombinase-aided amplification assay for the rapid detection of N gene of severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) Tao Wu, Yiyue Ge, Kangchen Zhao, Xiaojuan Zhu, Yin Chen, Bin Wu, et al. (+3)
40 [GO] 2020―Jun―13 Growth, detection, quantification, and inactivation of SARS-CoV-2 James Brett Case, Adam L. Bailey, Arthur S. Kim, Rita E. Chen, Michael S. Diamond
41 [GO] 2020―May―25 Recovery of severely ill COVID-19 patients by intravenous immunoglobulin (IVIG) treatment: A case series Negar Mohtadi, Abas Ghaysouri, Samira Shirazi, Elham Shafiee, Elham Bastani, Taleb Kokhazadeh, Hamed Tavan
42 [GO] 2020―May―19 The FDA-approved gold drug auranofin inhibits novel coronavirus (SARS-COV-2) replication and attenuates inflammation in human cells Hussin A. Rothan, Shannon Stone, Janhavi Natekar, Pratima Kumari, Komal Arora, Mukesh Kumar
43 [GO] 2020―Apr―30 Association of viral load with serum biomakers among COVID-19 cases Fengjuan Shi, Tao Wu, Xiaojuan Zhu, Yiyue Ge, Xiaoyan Zeng, Ying Chi, et al. (+6)
44 [GO] 2020―Feb―04 Hyper-phosphorylation of nsp2-related proteins of porcine reproductive and respiratory syndrome virus Pengcheng Shang, Fangfeng Yuan, Saurav Misra, Yanhua Li, Ying Fang


[de][en]

Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.005 sec